Search

Your search keyword '"Roukens, A."' showing total 676 results

Search Constraints

Start Over You searched for: Author "Roukens, A." Remove constraint Author: "Roukens, A."
676 results on '"Roukens, A."'

Search Results

2. A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion

4. Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

5. Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease

6. A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion

7. Total plasma N-glycomic signature of SARS-CoV-2 infection

8. The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization

9. Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial

12. Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose

14. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

17. Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers

21. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

22. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19

24. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial

26. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

27. Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score.

29. Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study

30. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.

31. Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

32. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

33. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

34. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

35. Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus:DUALING Prospective Nationwide Matched Cohort Study

36. Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

37. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19

39. C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition

40. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

41. Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance

44. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

45. OC 29.2 The Impact of Pulmonary Embolism on the Long-Term Health Outcomes of COVID-19

46. Safety and clinical impact of FEES – results of the FEES-registry

47. Consecutive antibiotic use in the outpatient setting: an extensive, longitudinal descriptive analysis of antibiotic dispensing data in the Netherlands

48. Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

49. Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

Catalog

Books, media, physical & digital resources